Ostomy Devices Global Market Report 2024

The ostomy devices market size has grown strongly in recent years. It will grow from $2.64 billion in 2023 to $2.8 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to the prevalence of gastrointestinal disorders, a rising incidence of colorectal cancer, improvements in surgical techniques, enhanced quality of ostomy products, increasing awareness, patient education, and supportive healthcare policies.

The ostomy devices market size is expected to see steady growth in the next few years. It will grow to $3.37 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to the aging population and chronic diseases, a focus on patient-centric products, advancements in materials and design, the global expansion of ostomy care awareness, telehealth, and remote patient monitoring, as well as healthcare system modernization. Major trends in the forecast period include environmentally friendly products, customization and personalization, awareness and education initiatives, healthcare cost containment, and global market expansion and accessibility.

The prevalence of colorectal cancer, characterized by uncontrolled cell growth in the colon or rectum, is expected to be a significant driving force behind the ostomy device market's growth. As colorectal cancer cases increase, there is a corresponding rise in the necessity for ostomy surgeries. Ostomy devices play a crucial role in assisting patients who have undergone colorectal cancer surgeries by aiding in waste collection and effectively managing bodily functions post-surgery through attachment to the stoma. For example, in January 2023, the American Cancer Society reported an escalation in colorectal cancer cases from 149,500 in 2021 to 153,020 in 2023, representing a growth rate of 2.35%. Hence, the heightened occurrence of colorectal cancer is expected to be a driving factor propelling the ostomy device market's growth.

The growing prevalence of urological diseases is anticipated to fuel the expansion of the ostomy devices market in the coming years. Urological diseases encompass various medical conditions impacting the urinary and male reproductive systems. Ostomy devices play a pivotal role in managing specific urological conditions by diverting urine away from the bladder or urinary tract. For instance, as per a 2021 report by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), urinary tract infections persist as prevalent bacterial infections among women, with 10% experiencing an infection annually and over 40% to 60% encountering an infection at least once in their lifetimes. Hence, the increasing prevalence of urological diseases significantly contributes to the ostomy devices market's expansion.

The prevalence of colorectal cancer is anticipated to be a driving force behind the growth of the ostomy device market. Colorectal cancer, characterized by uncontrolled cell growth in the colon or rectum, necessitates ostomy surgeries to manage bodily functions post-surgery. Ostomy devices aid patients post-colorectal cancer surgeries by assisting in waste collection and effective management through attachment to the stoma. For instance, the American Cancer Society reported an increase in colorectal cancer cases from 149,500 in 2021 to 153,020 in January 2023, marking a growth rate of 2.35%. Hence, the higher incidence of colorectal cancer is poised to propel the growth trajectory of the ostomy device market.

Key players in the ostomy device market are actively developing innovative materials, notably skin-friendly materials, to mitigate potential skin issues arising from prolonged device contact and gain a competitive edge. These materials aim to reduce skin irritation, allergies, or discomfort resulting from extended usage. For example, in June 2021, Welland Medical, a UK-based manufacturer specializing in ostomy bags and accessories, introduced the Aurum Plus range - a newly designed ostomy pouch featuring skin-friendly hydrocolloid material enriched with manuka honey. This innovation offers wound-healing and antibacterial properties for the skin surrounding the stoma. Additionally, incorporating body-hugging comfort curves enhances user comfort and diminishes the risk of outlet twisting, which could impede urine flow.

In April 2021, Schweitzer-Mauduit International Inc., a product engineering and manufacturing company headquartered in the United States, completed the acquisition of Scapa Group Plc for an undisclosed sum. This strategic acquisition was undertaken with the objective of enhancing Schweitzer-Mauduit International Inc.'s worldwide footprint and expanding its portfolio of high-performance materials and solutions tailored for both healthcare and industrial markets. Scapa Group Plc, based in the United Kingdom, is recognized for its specialization in manufacturing bonding products, ostomy supplies, and related accessories.

Major companies operating in the ostomy devices market report are 3M Company, Henkel AG And Co. KGaA, Avery Dennison Corporation, B. Braun Melsungen AG, Smith & Nephew plc, Coloplast Corp., ConvaTec Group PLC, Hollister Incorporated, Porex Corporation, Perma-Type Company Inc., Dansac UK, Salts Healthcare, Zhejiang Longterm Medical Technology Co. Ltd, Vonco Products LLC, Angiplast Pvt. Ltd., Scapa Healthcare Ltd, Welland Medical Limited, Flexicare (Group) Limited, Marlen Manufacturing And Development Company, Advacare Pharma USA LLC., Nu-Hope Laboratories Inc., Torbot Group Inc., Genairex Inc, ALCARE Co. Ltd., OxMed International GmbH, Cymed Inc, Schena Ostomy Technologies Inc., Sarasota Medical Products, Safe N' Simple LLC , Wuhan Sitaili Medical Apparatus Development Co. Ltd.

North America was the largest region in the ostomy devices market in 2023. The regions covered in the ostomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the ostomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ostomy device market consists of sales of pouching systems, skin barriers, belts and supports, and caps and plugs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The primary categories of ostomy devices include bags and accessories. Bags, made from medical-grade materials, serve as collection pouches to securely contain bodily waste redirected through a stoma. These bags offer leak-proof protection, odor prevention, and ensure hygiene and comfort for individuals with ostomies. They come in system types such as one-piece and two-piece systems, catering to surgical interventions such as colostomy, urostomy, and ileostomy. The end users of these devices include ambulatory surgical centers, hospitals, home care, and other healthcare facilities.

The ostomy devices market research report is one of a series of new reports that provides ostomy devices market statistics, including ostomy devices industry global market size, regional shares, competitors with a ostomy devices market share, detailed ostomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the ostomy devices industry. This ostomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future- scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.